Skip to content

[ Healing & recovery research ]

KLOW80 in Australia: a four-peptide healing-blend research guide

What KLOW80 is — a co-lyophilised research blend of BPC-157, GHK-Cu, TB-500 and KPV that extends the GLOW-family trio with an anti-inflammatory tripeptide — what each component brings, and how per-component content is HPLC-verified. A laboratory research reference for Australian researchers.

7 min read · Updated 22 July 2026

KLOW80 co-lyophilised research blend vial — BPC-157, GHK-Cu, TB-500 and KPV, independently HPLC-content-tested, COA on file

[ Research use only · Not for human consumption ]

KLOW80 in Australia. KLOW80 is a multi-component research blend supplied co-lyophilised in a single vial — BPC-157, GHK-Cu, TB-500 and KPV. It extends the GLOW-family healing trio with the melanocortin-derived tripeptide KPV. This guide is a research-reference summary for Australian researchers; it makes no medical or human-use claim.

Four research strands in one vial

KLOW80 is a formulation rather than a single chemical entity, so it has no single CAS number or molecular weight — each of its four peptides carries its own identity. BPC-157 and TB-500 (thymosin β-4) are the two soft-tissue-repair peptides; GHK-Cu is the copper-peptide; and KPV (Lys-Pro-Val, the C-terminal tripeptide of α-MSH) is the anti-inflammatory-pathway component. The blend co-presents four distinct research strands in one reconstitution (BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg + KPV 10mg).

How KLOW80 extends GLOW70

KLOW80 is the four-peptide extension of the GLOW70 healing trio (BPC-157, GHK-Cu, TB-500) — it adds KPV as a fourth component. Where GLOW70 co-presents two soft-tissue strands with a copper-peptide, KLOW80 adds the melanocortin-derived anti-inflammatory tripeptide strand studied by Kannengiesser and colleagues (Inflammatory Bowel Diseases, 2008) and Dalmasso and colleagues (Gastroenterology, 2008). The KPV research guide covers that component in depth.

The research behind the components

The soft-tissue-repair components are reviewed for BPC-157 by Seiwerth and colleagues (Frontiers in Pharmacology, 2021) and for thymosin β-4 by Goldstein and colleagues (Expert Opinion on Biological Therapy, 2012); GHK-Cu sits in the copper-peptide / dermal-remodelling strand reviewed by Pickart and Margolina. Because each of the four peptides is independently HPLC-content-tested by Janoshik, the blend’s certificate reports the measured content of every component rather than a single combined figure — the same research-honest standard applied across the GLOW-family blends.

Reconstitution, the blue tint, and compliance

The GHK-Cu component gives the reconstituted solution a characteristic blue tint from its copper coordination — expected, and a useful batch-consistency marker. Reconstitute the co-lyophilised vial with bacteriostatic water; the reconstitution guide covers the per-component concentration math. KLOW80 is not TGA-approved and is not a therapeutic good; Elite AU Peptides makes no medical or human-use claim, and supplies it strictly for in-vitro and laboratory research use only. The certificate is published on the product page and in the lab-reports library.

[ Frequently asked ]

Healing & recovery research — questions researchers ask.

What is in the KLOW80 blend?
KLOW80 is a multi-component research blend co-lyophilised in a single vial — BPC-157, GHK-Cu, TB-500 and KPV (BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg + KPV 10mg). Each component is independently HPLC-content-tested by Janoshik. Elite AU Peptides supplies it strictly for in-vitro and laboratory research use only — not for human or animal consumption, not a therapeutic good, and not TGA-approved.
How is KLOW80 different from GLOW70?
KLOW80 extends the GLOW70 healing trio (BPC-157, GHK-Cu, TB-500) with a fourth component — the melanocortin-derived tripeptide KPV. GLOW70 is the three-peptide blend; KLOW80 is the four-peptide blend. See the GLOW70 guide for the trio.
What does the KPV component bring?
KPV (Lys-Pro-Val, the C-terminal tripeptide of α-MSH) sits in the anti-inflammatory-pathway research strand — studied, for example, by Kannengiesser and colleagues in murine models (Inflammatory Bowel Diseases, 2008) and shown to enter cells via the PepT1 transporter by Dalmasso and colleagues (Gastroenterology, 2008). It adds a fourth distinct research strand to the healing blend. See the KPV research guide for detail.
How is a four-peptide blend tested?
Every batch is independently HPLC-content-tested by Janoshik. The certificate reports the measured content of each of the four components rather than a single combined purity figure — the same research-honest standard applied to the GLOW-family blends. Nothing is listed without certificates on file.
Why does reconstituted KLOW80 turn blue?
The GHK-Cu component is a copper(II) complex; its coordination chemistry gives the reconstituted solution a characteristic blue tint — expected, and a useful batch-consistency marker.
How is KLOW80 reconstituted and shipped?
Reconstitute the co-lyophilised vial with bacteriostatic water; the per-component content on the certificate is the reference for the concentration math. Dispatched AU-domestic, free shipping over $100, same-day dispatch before 12pm AEST. Supplied strictly for laboratory research use only.

Elite AU Peptides supplies research peptides and related compounds for laboratory and in-vitro research use only. Products are not therapeutic goods, are not TGA-approved, and are not for human or animal consumption. Nothing on this site constitutes medical advice or a therapeutic claim. Purchasers must be 18 years or older and are responsible for complying with all applicable laws in their jurisdiction.